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Multidrug and toxic compound extrusion (MATE) transport proteins confer multidrug
resistance on pathogenic microorganisms and affect pharmacokinetics in mammals. Our
understanding of how MATE transporters work, has mostly relied on protein structures and
MD simulations. However, the energetics of drug transport has not been studied in detail.
Many MATE transporters utilise the electrochemical H+ or Na+ gradient to drive substrate
efflux, but NorM-VC from Vibrio cholerae can utilise both forms of metabolic energy. To
dissect the localisation and organisation of H+ and Na+ translocation pathways in NorM-VC
we engineered chimaeric proteins in which the N-lobe of H+-coupled NorM-PS from Pseu-
domonas stutzeri is fused to the C-lobe of NorM-VC, and vice versa. Our findings in drug
binding and transport experiments with chimaeric, mutant and wildtype transporters highlight
the versatile nature of energy coupling in NorM-VC, which enables adaptation to fluctuating
salinity levels in the natural habitat of V. cholerae.
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The members of the multidrug and toxic compound extru-sion (MATE) family are widely distributed in bacteria,archaea, and eukarya1. The MATE family belongs to the
multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) trans-
porter superfamily which, based on sequence similarity, is further
classified in prokaryotic NorM and DinF subfamilies and the
eukaryotic MATE (eMATE) subfamily2,3 (Fig. 1a). The bacterial
MATE proteins transport amphiphilic cationic drugs, such as
norfloxacin and ethidium, from the cellular interior. Plant MATE
transporters have physiological roles in herbicide resistance,
sequestration of plant-derived organic compounds in vacuoles,
leaf senescence, aluminium tolerance, iron homoeostasis, and
synthesis of auxins4. In mammals, MATE transporters are loca-
lised in the proximal convoluted tubule and proximal straight
tubule in the kidney, as well as the canalicular membrane in
hepatocytes, where they mediate transport of organic cations in
the final steps of drug elimination from the body3,5. Owing to
their involvement in a wide range of physiological processes,
MATE transporters are attractive pharmaceutical targets.
The structures of MATE transporters show that these proteins
contain 12 transmembrane helices (TMs) that are organised in
two 6 TM domains, referred to as N-lobe and C-lobe (Fig. 1a, b).
These helices are arranged differently from those in major facil-
itator superfamily (MFS) transporters6,7, supporting earlier con-
clusions that MATE and MFS proteins should be regarded as
separate protein families2. Over the past decades, the evolutionary
persistence of alternating access mechanisms has been shown for
a variety of membrane transporters. Via sequential conforma-
tional changes, the transporter alternates between two major
conformations, one of which exposes a central substrate-binding
pocket to the cellular interior, and the other exposes this pocket
to the exterior of the cell. For MATE transporters, the structural
details and catalytic reactions underlying the necessary con-
formational changes are still only partly understood. In part, this
is because all, but two crystal structures of MATE transporters
have been reported in the outward-facing conformation (Fig. 1a).
Transporters in the MATE family were originally described to
mediate drug/ion antiport in a Na+ or H+-coupled fashion. X-ray
crystallographic studies suggest that the NorM subfamily is
dependent on Na+ coupling in the C-lobe7,8, the eMATE sub-
family requires H+ coupling in the C-lobe9,10, and the DinF
subfamily utilises H+ coupling in the N-lobe11–15. Further
structural investigations on two members of the DinF family
suggest the presence of a Na+-binding site in their N-lobes, but
this Na+ dependency was not demonstrated in drug transport
measurements or biochemical assays16–18. In fact, as the progress
in the MATE transporter field has mostly relied on protein
structural techniques19, the energetics of MATE transporters has
not been studied systematically with well-established methods in
proteoliposomes and intact cells, developed over decades of
transporter research. Therefore, the ion/drug stoichiometries and
dependencies of the antiport reactions on chemical ion gradients
and the membrane potential are mostly unknown. Using these
methods in our previous study, we identified the ability of NorM
from Vibrio cholerae (NorM-VC) to utilise both the H+ and Na+
gradient in its drug-efflux activity20. Follow-up biophysical
measurements on NorM-VC based on double-electron electron
resonance (DEER) spectroscopy confirmed the existence of Na+-
and H+-bound intermediates in NorM-VC21. Here, we study the
ion-translocation pathways in NorM-VC and their bioenergetic
contributions to drug efflux in transport measurements, drug
binding assays and molecular dynamics (MD) simulations. In
contrast to NorM-VC, the NorM orthologue in Pseudomonas
stutzeri (NorM-PS) (Fig. 1c) was reported to be solely dependent
on H+ coupling22,23. We prepared NorM-VC/NorM-PS chi-
maeras and mutant proteins that enabled us to dissect the
localisation of ion-coupling events and roles of conserved cata-
lytic carboxylates in H+ binding and Na+ coordination.
Results
H+ and Na+ dependence in NorM-VC-mediated ethidium
efflux. Our investigations focussed on NorM proteins expressed in
Lactococcus lactis ΔlmrA ΔlmrCD. This organism is ideal for this
purpose due the reduced expression of endogenous multidrug
transporters and the ease of manipulation of bioenergetic para-
meters in substrate transport measurements (see ‘Bioenergetic
considerations’ in ‘Methods’). As ethidium shows an enhancement
of fluorescence emission upon binding to nucleic acids in the
cellular interior, the efflux of ethidium is associated with a
fluorescence decrease. Following the addition of glucose to
ethidium-loaded cells expressing NorM-VC, the generation of
ATP and proton motive force (Δp, interior negative and alkaline)
activate ethidium efflux (Fig. 2a). This efflux was significantly
enhanced when 1 mM Na+ was added to the buffer. To further
study these transport reactions, cells were suspended in Tris
buffer. The lack of K+ in this buffer disables the membrane
potential (Δψ, interior negative)-dependent K+ uptake in the cells
that allows the controlled dissipation of the Δψ and establishment
of a transmembrane chemical proton gradient (ΔpH, interior
alkaline) during proton export by the plasma membrane F0F1 H+-
ATPase24. The restoration of robust ethidium efflux following the
addition of 10 mMK+ to the buffer points to the importance of
the ΔpH as a driving force for ethidium efflux (Fig. 2b). The
establishment of a sodium motive force (ΔpNa, interior negative
and low) in these cells, facilitated by the addition of 10mM Na+
instead of K+, also significantly stimulated ethidium efflux by
NorM-VC. Determination of initial ethidium efflux rates as a
function of the Na+ concentration yielded an apparent affinity
constant Kt of 0.39 ± 0.06mM Na+ (Fig. 2c), which is comparable
to previously reported data20. These results suggest that NorM-
VC can use both Na+ and H+ as coupling ions. Strikingly, when
these experiments were repeated with lactococcal cells expressing
the NorM-VC homologue NorM-PS from P. stutzeri22,23, the
ethidium efflux reaction was stimulated by K+ but not by Na+
(Fig. 2a, b). Therefore, the mechanisms of energy coupling to
ethidium efflux in NorM-VC and NorM-PS are different.
Effect of the H+ and Na+ availability in ion coupling in NorM-
VC. To study energy coupling by NorM-VC in more detail,
ethidium transport in cells was measured at different con-
centrations of H+ and Na+ in the external buffer under condi-
tions where the magnitude and composition of the Δp was
manipulated with the ionophores nigericin and/or valinomycin.
The effect of the ionophores was first tested in measurements of
the Δψ using DiOC2(3) (Fig. 3a, b). This lipophilic cationic probe
accumulates in the interior of cells at the negative side of the
polarised plasma membrane, where the increased probe con-
centration is associated with fluorescence intensity enhancement.
Following the sequential additions of glucose, nigericin and
valinomycin to the cells, three levels of DiOC2(3) fluorescence are
observed (indicated in the top panel of Fig. 3a). Level (i) reflects
the Δψ (interior negative) in glucose-metabolising cells in the
absence of the ionophores. Level (ii) was reached following the
addition of 0.5 µM nigericin. Nigericin mediates electroneutral
(Δψ-independent) H+/K+ exchange across the plasma mem-
brane, which leads to the interconversion of ΔpH into extra Δψ
(interior negative)25, transforming Δp= Δψ− ZΔpH into Δp=
Δψ+ extra Δψ. Finally, Level (iii) was reached following the
addition of 0.1 µM valinomycin, which mediates electrogenic
(Δψ-dependent) K+ uniport across the plasma membrane and
causes the dissipation of the Δψ and reduction of the DiOC2(3)
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fluorescence to baseline level. These measurements demonstrate
that the Δp is relatively constant at an external pH of 6.0, 7.0 and
8.0 (Fig. 3b). Due to homeostasis of the internal pH in the cells
(pHin is constant at approx. 7.8–8.0)24, the contribution of the
ΔpH to the Δp is highest at pH 6.0 whereas the contribution of
the Δψ is highest at pH 8.0. The addition of 1 mM Na+ did not
cause significant shifts in the magnitude and composition of the
Δp at the different pH values (Fig. 3b).
Having established the effect of ionophores on the Δψ, ΔpH
and Δp in our lactococcal cells, the ionophores were used in
ethidium efflux experiments with the cells suspended in KPi
buffer pH 6.0, 7.0 and 8.0 in the absence or presence of 1 mM
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Na+ (Fig. 3c). At pH 6.0, the active efflux of ethidium by NorM-
VC in the presence of nigericin (Δψ only) was similar to the
control where both ionophores were added simultaneously (no
Δp). This is due to the low internal pH that is inhibitory for
NorM-VC activity (pHin equals the pH of buffer in which cells
are suspended). However, in the presence of valinomycin (ΔpH
only) or absence of ionophores (Δp), NorM-VC was transport-
active; this activity was not affected by the inclusion of 1 mM Na+
in the external buffer. These data point to the dominance of
proton coupling and lack of Na+ coupling to ethidium efflux at
pH 6.0. In further descriptions of ethidium transport experi-
ments, the ionophore additions will not be repeated. Instead, we
will refer to the electrochemical forces driving the efflux (Δp,
ΔpH, Δψ or none) that are present in the cells. At pH 7.0 and pH
8.0, where the H+ concentration is 10-fold and 100-fold lower
compared to pH 6.0, ethidium efflux by NorM-VC was
dependent on both the Δψ and ΔpH, consistent with electrogenic
antiport of ethidium+ and two or more protons (Fig. 3c). The
imposition of an inwardly-directed chemical Na+ gradient
(ΔpNa, interior low) significantly stimulated ethidium efflux in
NorM-VC-expressing cells relative to non-expressing control cells
in the presence of the Δp at pH 7.0 and ΔpH and Δψ at pH 8.0
(Fig. 3d). The ΔpNa also significantly stimulated NorM-VC-
dependent ethidium efflux for the no-Δp control at pH 8.0.
Therefore, no further stimulation of ΔpNa-dependent efflux
activity at this pH was obtained by the additional imposition of
the Δp (Fig. 3d). Two conclusions can be drawn from these
experiments. First, similar to H+-coupled ethidium efflux by
NorM-VC, Na+-coupled ethidium efflux is based on an
electrogenic transport reaction. Second, Na+ coupling in
NorM-VC is more pronounced for cells in buffer pH 8.0 than
6.0 or 7.0, indicating that the ability of NorM-VC to couple to the
Δp and ΔpNa is affected by the relative availability of Na+ and H+
in the external environment.
Biochemical studies on Na+ and H+ binding in NorM-VC. The
interaction of NorM-VC with Na+ and H+ was further investi-
gated in a biochemical assay in which ethidium binding was used
as a reporter (Fig. 4a). Samples of freshly purified proteins in
detergent solution were added in a stepwise manner to a KPi
buffer (pH 7.0) containing a fixed 2 µM concentration of ethi-
dium. At each addition of protein, the fluorescence anisotropy
was recorded for about 2 min until a constant value was reached.
In the presence of 1 mM Na+, the ethidium binding data were
biphasic, with high-affinity binding superimposed on low-affinity
binding. Non-linear fitting of the data to a two-sites specific-
binding model revealed an apparent Kd below 40 nM protein for
high-affinity binding and an apparent Kd above 0.2 µM protein
for low-affinity binding (Fig. 4a). In the absence of Na+, the
ethidium binding data reflect hyperbolic low-affinity binding
only, due to the loss of the high-affinity ethidium binding. These
results indicate that the interaction of Na+ with NorM-VC sta-
bilises a conformation that binds ethidium with high affinity. In a
dynamic equilibrium, this conformation coexists with Na+-free
conformations exhibiting low-affinity ethidium binding. The
results are consistent with the enhanced UV cross-linking of
azido-ethidium to NorM-VC in the presence of Na+ 20.
NorM-VC contains conserved carboxyl residues, D36 at the
external face of the N-lobe and E255 and D371 at the centre of
the C-lobe (Fig. 1b), that might catalyse proton binding and/or,
when deprotonated, contribute to Na+ coordination. When the
ethidium binding assays were repeated with mutants D36N,
E255Q, and D371N, containing single carboxyl-to-amide sub-
stitutions that mimic the protonated carboxylic acid side chain,
the Na+-dependent high-affinity ethidium binding was lost
(Fig. 4a). Therefore, the N- and C-lobe of NorM-VC might
contain a Na+ binding pocket. Indeed, crystal structures of
NorM-VC (PDB-ID: 3MKT and 3MKU) have the Na+ analogues
Rb+ or Cs+ bound near E255 and D371. For NorM from
Neisseria gonorrhoeae (PDB-ID: 4HUL) a Cs+ ion is bound at the
equivalent position. However, in our assays with wildtype NorM,
ethidium binding was low-affinity in the presence of 1 mM Cs+,
Rb+ or Li+ (Fig. 4a) suggesting that, although these Na+
analogues might mimic a bound Na+ ion in the crystal structures,
they do not mimic Na+ binding at the functional level. This
might relate to the differences in atomic radii and coordination
chemistry of these ions.
In biochemical studies on H+ interactions in NorM-VC, the
binding of ethidium to wildtype protein increased dramatically
and in a double sigmoidal fashion when the buffer pH was
increased from pH 6 to 9 (Fig. 4b). The two midpoints at pH 6.9
and 8.0 suggest apparent pKa values of proton binding to NorM-
VC. Among the D36N, E255Q and D371N mutants, only D371N
retained ethidium binding, but with a much lower rise around the
second midpoint. Given that the pKa values of carboxylates near
the external membrane surface will be lower than those near the
internal surface to allow protonation and deprotonation in
response to a ΔpH (interior alkaline), it is likely that the first
midpoint represents the pKa of D36 while the second midpoint
represents the sum of pKa values of E255 and D371. These data
reinforce previous observations that proton release is required for
ethidium binding to NorM-VC20. When taken together, the
results from these biochemical studies highlight the impact of
Na+ and H+ interactions in NorM-VC on ethidium binding to
the transporter.
Role of catalytic carboxylates in energy coupling in NorM-VC.
The contribution of catalytic carboxylates to energy coupling in
NorM-VC was studied in more detail. The D36N mutants
exhibited significant ethidium efflux activity in the presence of the
Fig. 1 Structural features of MATE transporters. a Overview of MATE subfamilies showing the V-shaped outward-facing structures of plant eMATE
transporters from Camelina sativa (CasMATE, PDB-ID: 5XJJ)9 and Arabidopsis thaliana (AtDTX14, PDB-ID: 5Y50)10, NorM transporters from Vibrio cholerae
(NorM-VC, PDB-ID: 3MKT)7 and Neisseria gonorrhoeae (NorM-NG, PDB-ID: 4HUK)8,13 and DinF transporters from Escherichia coli (ClbM, PDB-ID:
4Z3N)60, V. cholerae (VcmN, PDB-ID: 6IDP)14 and Pyrococcus furiosus (PfMATE, PDB-ID: 3VVN)11. In these structures the N- and C-terminal halves,
referred to N- and C-lobes, contact each other at the intracellular side. Also shown are the inward-facing conformation of PfMATE (PDB-ID: 6FHZ)16 and
closed-outward conformation of DinF-BH from Bacillus halodurans (PDB-ID: 4LZ6)12. Transmembrane helices (TMHs) are shown in rainbow colours with
TMH1-6 in blue–green and TMH7-12 in yellow–orange–red. Dotted lines depict the approximate membrane boundaries. b Structure of NorM-VC (PDB-ID:
3MKT)7 in three different orientations, showing the locations of catalytic carboxylates D36 in the N-lobe and E255 and D371 in the C-lobe as spheres.
c Alignment of amino acid sequences for NorM-VC (AAF94694.1) from Vibrio cholerae serotype O1 (ATCC 39315), NorM-PS (EHY79494.1) from
Pseudomonas stutzeri strain ZoBell (ATCC 14405) and NorM-NG (WP_003687823.1) from Neisseria gonorrhoeae. The alignment indicates the location of
the transmembrane helices and shows that D36, E255 and D371 in NorM-VC are conserved as D38, E257 and D373 in NorM-PS, and D41, E261 and D377
in NorM-NG. The conservation of residues Q278 and N282 in NorM-VC (see Fig. 9) is indicated in the open blue boxes. The protein structures were
prepared in Pymol v2.4.0; the sequence alignment was generated in Clustal Omega v1.2.4.
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ΔpH or Δp (Fig. 5a) relative to the no-Δp condition. However,
different from wildtype NorM-VC (Fig. 3c, d), no efflux activity
was seen in the presence of the Δψ only. Furthermore, the Na+-
dependent stimulation of ethidium efflux by wildtype NorM-VC
was lost for the D36N mutant (Fig. 5a). Clearly, the mutant lacks
the input of H+ or Na+ that usually enters the reaction via D36 at
the external side of the transporter and, as a consequence,
mediates electroneutral ethidium+/H+ antiport rather than the
electrogenic ethidium+/(H+, Na+) antiport observed for wildtype
NorM-VC. Regarding the E255-D371 region, a previous study
established the complete inhibition of ethidium transport in the
E255Q mutant as well as electroneutral ethidium/Na+ antiport by
the D371N mutant20. We repeated these measurements for
NorM-VC-D371N in the absence of Na+ and obtained evidence
for electroneutral ethidium/H+ antiport (Fig. 5b). These findings
highlight the importance of the D36 and E255-D371 regions for
the coupling of NorM-VC to the electrochemical Na+ and H+
gradients.
Ion coupling in NorM-PS differs from NorM-VC. In similar
experiments for NorM-PS, this transporter showed a significant
ethidium efflux activity in the presence of the ΔpH or Δp (Fig. 6a)
but no efflux activity with the Δψ only. The energetics of ethidium
efflux by NorM-PS is, therefore, comparable to NorM-VC-D36N
and consistent with electroneutral ethidium+/H+ antiport.
Regarding the conserved catalytic carboxylates (Fig. 1c), the
D38N mutation in the N-lobe had no noticeable effects on Δp-
dependent ethidium efflux activity relative to wildtype NorM-PS
(Fig. 6b), whereas the E257Q and D373N mutations in the C-lobe
significantly inhibited ethidium efflux with residual activity for
the D373N mutant relative to the non-expressing control
(Fig. 6b). Finally, neither ethidium efflux (Fig. 2a, b) nor ethidium
binding (Fig. 4a) were stimulated in the presence of 1 mM Na+
suggesting that wildtype NorM-PS is unable to use Na+ in its
transport mechanism. When taken together, these results indicate
that, unlike D36 in NorM-VC, D38 in NorM-PS is catalytically
silent in our measurements.
The ability of Na+ to interact with D36 in NorM-VC and D38
in NorM-PS was also compared in molecular dynamics (MD)
simulations in two complementary approaches. First, in a Na+
dissociation study, four independent MD simulations were
performed with outward-facing NorM-VC with pre-bound Na+
in a binding pocket in the N-lobe that is formed by deprotonated
D36, N174, N178 and G195 (Fig. 7a, b). When the MD
simulations were started, the pre-bound Na+ ion was retained
in all four simulations for NorM-VC (Fig. 7b) and was released
from the pocket upon protonation of D36 (Fig. 7c). In contrast, in
two of four simulations with deprotonated D38 in NorM-PS, Na+
was not retained but diffused away from the D38 pocket within
100 ns (Fig. 7d, e). Based on contributions to Na+ binding of
residues within 0.8 nm of the ion, the calculated interaction energy
for NorM-VC in the last 10 ns was significantly larger than for
NorM-PS (−215 ± 30 kJ/mol versus −129 ± 85 kJ/mol, respec-
tively). These simulations suggest that the D36 pocket in NorM-
VC retains bound Na+ more easily than the D38 pocket in NorM-
PS. Second, in a Na+ association study, the interaction of Na+
with the D36 and D38 pockets was compared by simulating the
movement of the free ion into the empty pockets over a time span
of 500 ns. When the D36 pocket in NorM-VC was exposed to Na+
at the start of the MD simulation, the ion associated with the D36
pocket in three out of four simulations with NorM-VC (Fig. S1).
However, no binding of Na+ in the D38 pocket was observed in
the four simulations with NorM-PS (Fig. S1). Evidently, despite
the extensive sequence similarity between NorM-VC and NorM-
PS (Fig. 1c), these proteins differ in their Na+ binding properties.
It is noteworthy that when the molecular electrical potential
surfaces at the external side of outward-facing NorM-VC and
NorM-PS are compared, NorM-VC is more electronegative due to
the presence of acidic surface residues. These are replaced by basic
and hydrophobic residues in NorM-PS (Fig. S2). As a result of this
difference, NorM-VC will have a stronger electrostatic attraction
for Na+ ions in the external buffer.
Fig. 2 Comparison of Na+ dependency of NorM-VC and NorM-PS. a Upon
the addition of 20mM glucose (+G), cells expressing NorM-VC (red
traces) or NorM-PS (cyan traces) show significant ethidium efflux over
time compared to non-expressing control cells (grey traces). The presence
of 1 mM Na+ in buffer pH 7.0 (dotted traces) stimulates efflux activity by
NorM-VC but not by NorM-PS. The histogram on the right shows mean
levels of ethidium fluorescence at 400 s in repeat experiments. Open bars,
-Na+. Horizontally-striped bars, +Na+. b In a K+-free Tris buffer, ethidium
efflux by NorM-VC in glucose-metabolising cells (yellow trace) is
stimulated by the addition of 10 mM Na+ (black trace) or K+ (pink trace),
indicating that the ΔpNa and ΔpH can each be a driving force for transport.
In contrast, ethidium efflux by NorM-PS is only stimulated by K+ but not by
Na+. Histograms show mean levels of ethidium fluorescence at 600 s in
repeat experiments. Open yellow bars, MATE transporter-expressing cells
in Tris buffer. Black or pink horizontally-striped bars, +Na+ or +K+,
respectively. c Active ethidium efflux by NorM-VC as a function of the Na+
concentration (rainbow coloured) in buffer pH 7.0. A plot of the efflux rates
versus Na+ concentrations was fitted to a hyperbola. Data represent
observations in three experiments with independently prepared batches of
cells. Values are expressed as mean ± s.e.m. (two-way analysis of variance;
**P < 0.01; ****P < 0.0001). Asterisks above square brackets refer to
comparisons with the no-Na+ condition (a), whereas asterisks directly
above bars refer to comparisons with Tris buffer only (b); ns indicates ‘not
significant’.
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Fusions of N- and C-lobes of NorM-VC and NorM-PS give rise
to transport-active chimaeric transporters. NorM-VC and
NorM-PS are homologous proteins that share 41% identical plus
18% similar residues and contain conserved catalytic carboxylates
(Fig. 1c). To further investigate structural differences in the N-
and C-lobes of NorM-VC and NorM-PS that might be respon-
sible for the differences in ion coupling, chimaeric proteins were
constructed. The coding sequence for the N-lobe of NorM-VC
(residues 1–224) was fused to the coding sequence for the C-lobe
of NorM-PS (residues 227–464) (Figs. 8a and 1c), yielding chi-
maeric nVC-cPS. The second chimaera (termed nPS-cVC) was
constructed by fusing the coding sequence of the N-lobe of
NorM-PS (residues 1–226) to that of the C-lobe of NorM-VC
(residues 225–461) (Figs. 8a and 1c). The chimaeric proteins were
expressed in the plasma membrane of L. lactis under identical
experimental conditions and at expression levels that were in a
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comparable range as NorM-VC and NorM-PS (Fig. 8b and S3).
The higher mobility of the monomer signal of NorM-PS com-
pared to NorM-VC on SDS-PAGE is consistent with previous
studies20,22. It is also observed for chimaeras containing the C-
lobe of NorM-PS (nVC-cPS, and nVC-cPS-D36N) and is most
likely due to increased SDS binding to the C-lobe of NorM-PS.
The nVC-cPS and nPS-cVC transporters were both ethidium
efflux-active. For each of the chimaeras, the efflux was strictly
dependent on the presence of the ΔpH (interior alkaline),
whereas no ethidium transport was seen in the presence of the Δψ
only (Fig. 8c). Thus, both chimaeras mediate electroneutral
ethidium+/H+ antiport analogous to NorM-VC-D36N (Fig. 5a)
and wildtype NorM-PS (Fig. 6a). The inhibitory effect of D36N in
the N-lobe of nVC-cPS suggests that D36 must remain
dissociated for activity of this chimaera (Fig. 8c). On the other
hand, the neutral response of D38N in the N-lobe of nPS-cVC
(Fig. 8c) follows the observations for NorM-PS (Fig. 6b). Neither
of the nVC-cPS and nPS-cVC transporters showed a response to
1 mM Na+ during Δp-dependent ethidium efflux at pH 7.4,
where Na+ has a 25,000-fold excess over H+ (Fig. 8d). This was
corroborated in ethidium binding experiments with purified
chimaeric proteins in which Na+ did not enhance the ethidium
binding affinity (Fig. 4a). Clearly, Na+ coupling is lost when the
N-lobe or C-lobe in NorM-VC is replaced by the corresponding
lobe in NorM-PS, suggesting that the underlying mechanism
employs specific communication between the native N- and
C-lobes. To further test this notion, experiments focused on the
amide residues Q278 and N282, which are located at the N-lobe:
C-lobe interface in an inward-facing model of NorM-VC (Fig. 9a)
and which are conserved in NorM-PS (Fig. 1c). The NorM-VC-
Q278A and NorM-VC-N282A mutants were still ethidium
transport-active, but the transport reaction was no longer
stimulated by 1 mM Na+ (Fig. 9b). Further tests on the transport
energetics of the Q278A mutant demonstrate electroneutral
ethidium+/H+ antiport (Fig. 9c), and hence, the loss of a proton
in the transport reaction compared to wildtype NorM-VC. These
results indicate that electrogenic ethidium+/(H+, Na+) antiport
and ethidium+/2H+ antiport in NorM-VC require a specific
interface between the N-lobe and C-lobe.
Discussion
In this work, we studied the mechanism of energy coupling in
NorM-VC and obtained data that extend previous suggestions
based on structural approaches. In particular, our results
demonstrate the presence of two distinct ion-translocation
pathways in NorM-VC. Pathway 1 is H+-selective, active in the
C-lobe, and involves E255 and D371. Pathway 2 is promiscuous
for Na+ and H+ as alternative coupling ions, starts at D36 in the
N-lobe, and proceeds across the domain interface to E255 in the
C-lobe. To facilitate a further discussion of the data, we refer to
the schematic and summary of functional properties of mutants
in Fig. 10.
The measurements of ethidium efflux as a function of the
magnitude and composition of the Δp indicate that wildtype NorM-
VC mediates a Δψ-dependent (electrogenic) ethidium+/nH+ anti-
port reaction in which n ≥ 2 (Fig. 3c, d), whereas the D36N
mutant exhibits Δψ-independent (electroneutral) ethidium+/H+
antiport (Fig. 5a). The simplest model that explains these
observations is one where NorM-VC catalyses electrogenic ethi-
dium+/2H+ antiport (n= 2). When the experiments were repe-
ated in the presence of Na+, the Na+ dependency of energy
coupling to the wildtype NorM-VC was found to increase with
the alkalinity of the assay buffer. Furthermore, the D36N muta-
tion was associated with a complete loss of the Na+ coupling,
resulting in electroneutral ethidium+/H+ antiport (Fig. 5a). These
results imply that the D36 pocket can use H+ or Na+ as alter-
native coupling ions depending on their availability, and that the
Na+ coupling in NorM-VC causes a shift from electrogenic
ethidium+/2H+ antiport to electrogenic ethidium+/(Na+, H+)
antiport. In these experiments, Na+ could not be replaced
by Rb+, Cs+ or Li+ (Fig. 4a). The Na+–H+ promiscuity of
the D36 binding pocket is supported by our MD simulations
of Na+ binding to outward-facing NorM-VC in a phospholipid
bilayer (Fig. 7 and S1). These simulations show that the binding
of Na+ over H+ at high Na+/H+ ratios originates from
the inhibition of Na+ binding in the D36 pocket by protonation
of D36. It should be noted that while the biochemical assays
in this work measure the activity of populations of non-
synchronised transporters over minutes, the molecular events
underlying substrate and ion translocation in individual trans-
porters occur in the nanosecond time scale. Therefore, the time
scales used in our MD simulations are appropriate to model the
transport reactions.
As a previous study on the NorM-VC homologue NorM-PS in
P. stutzeri reported on H+-coupled drug transport23, we com-
pared the energetics of both MATE transporters under identical
experimental conditions. We observed that wildtype NorM-PS
mediates electroneutral ethidium+/H+ antiport in a Na+-inde-
pendent fashion in a buffer pH range of 6.0–8.0 (Fig. 6a) and
exhibits ethidium binding in a Na+-independent fashion
(Fig. 4a). Furthermore, our MD simulations show impaired Na+
binding in the D38 pocket of NorM-PS relative to the D36 pocket
Fig. 3 Energetics of H+- and Na+-coupled ethidium efflux in NorM-VC. a The composition of the Δp in cells suspended in buffer pH 6.0, 7.0, and 8.0 was
assessed using the fluorescent membrane potential probe DiOC2(3). When added to control cells, the probe reported three plateau levels in fluorescence
emission (see top panel). Level (i) reflects probe accumulation in the absence of ionophores due to the Δψ (interior negative) in glucose-energised cells in
which Δp=Δψ− ZΔpH. Level (ii) reports further probe accumulation following the addition of 0.5 µM nigericin (+N), which causes the interconversion of
the ΔpH into extra Δψ and provides a measure for the Δp (=Δψ+ extra Δψ). Level (iii) follows the addition of 0.1 µM valinomycin (+V), which causes the
dissipation of the Δψ and decrease of the DiOC2(3) fluorescence to baseline level. The histograms on the right represent Δψ= level (i) – level (iii) (blue
bars), ΔpH= level (ii)− level (i) (pink bars) and Δp= level (ii) – level (iii) (orange bars). The additions of the probe (+DiOC2(3)), nigericin (+N) and
valinomycin (+V) are labelled in the top panel. bMagnitudes and compositions of the Δp in (a) as a function of buffer pH. c Effect of the buffer pH 6.0, 7.0
and 8.0 on ethidium efflux in NorM-VC expressing cells or non-expressing control cells in absence of ionophores (Δp) (orange traces) or presence of
nigericin (Δψ only) (blue traces), valinomycin (ΔpH only) (pink traces), or both ionophores (no Δp) (green traces). The ionophores were added 3min
prior to the addition of the glucose (+G). Measurements were performed in the absence or presence of 1 mM Na+ as indicated on the left. Histograms on
the right show levels of ethidium fluorescence at 300 s in repeat experiments. Open bars, non-expressing control cells. Diagonally-striped bars, NorM-VC-
expressing cells. d Ethidium efflux activity as a function of buffer pH and driving force, in absence of Na+ (open bars) or presence of Na+ (horizontally-
striped bars). For calculation of bar heights, ethidium fluorescence levels at 300 s in (c) for cells without NorM-VC expression were subtracted from
corresponding levels for cells with NorM-VC expression. Data represent observations in three experiments (n= 3) with independently prepared batches of
cells. Values are expressed as mean ± s.e.m. (two-way analysis of variance; *P < 0.05; ***P < 0.001; ****P < 0.0001). The asterisks above or below square
brackets refer to comparisons with the non-expressing control in (c) or no-Na+ condition in (d); ns indicates ‘not significant’.
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a  Effect of Na+ and other cations on ethidium binding to NorM proteins at pH 7.0
NorM-VC-D36N NorM-VC-D371N NorM-VC-E255Q
no addition



























































b  Effect of H+ on ethidium binding to 0.2 μM NorM-VC (no Na+)































Fig. 4 Equilibrium ethidium binding to NorM proteins. a Purified NorM proteins in detergent solution were added stepwise to buffer pH 7.0 containing 2
μM ethidium in the absence of Na+ (red symbols) or presence of 1 mM Na+ (blue symbols) or Li+, Cs+, or Rb+ (purple, green and orange symbols,
respectively), after which the fluorescence anisotropy was measured. Na+ stimulates high-affinity binding of ethidium to wildtype NorM-VC but not to the
NorM-VC mutants D36N, D371N and E255Q, or NorM-PS or chimaeric proteins. b Ethidium binding to NorM-VC proteins was measured as a function of
buffer pH at 0.2 µM purified NorM-VC and 2 µM ethidium. Ethidium binding to wildtype protein exhibits a double sigmoidal increase as the pH is raised,
from which two midpoint pKa values of 6.9 and 8.0 were derived by non-linear curve fitting. Data represent observations in three experiments with
independently prepared batches of purified proteins. Values are expressed as mean ± s.e.m. Some error bars are hidden behind the data point symbols.
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in NorM-VC (Fig. 7 and S1). Moreover, the introduction of the
D38N mutation, which should disable H+ binding to and dis-
sociation from D38, did not inhibit ethidium efflux by NorM-PS
(Fig. 6b). Thus, the D38 pocket does not contribute to H+ or Na+
coupling in these experiments. A crystal structure for PfMATE
(PDB-ID: 3VVP) shows deep binding of norfloxacin in the N-
lobe, which causes conformational changes that impair the
binding of coupling ions in the D41 pocket11. For NorM-VC and
NorM-PS, it is interesting to note that the fluorescence anisotropy
responses for ethidium binding in Fig. 4a fall into two groups.
NorM proteins containing the N-lobe of NorM-VC (NorM-VC ±
Na+, Rb+, Cs+ or Li+; NorM-VC mutants D36N, E255Q, and
D371N ± Na+; and nVC-cPS chimaera ± Na+) have a high mean
fluorescence anisotropy value of 0.139 ± 0.004 at 1 µM protein,
whereas the NorM proteins containing the N-lobe of NorM-PS
(NorM-PS ± Na+ and the nPS-cVC ±Na+) have a significantly
lower mean value of 0.096 ± 0.006 (P < 0.0001 in unpaired two-
tailed student t-tests). These differences indicate that the inter-
action of NorM proteins with ethidium is, at least in part, dictated
by the N-lobe. If so, ethidium binding to NorM-PS might impair
the interactions of coupling ions in the D38 pocket similarly as
reported for D41 pocket in PfMATE. As D36 in NorM-VC is
functional in electrogenic ethidium+/(H+, Na+) antiport
(Fig. 5a), the molecular details of ethidium binding in the N-lobes
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Fig. 5 Role of catalytic carboxylates D36 and D371 in ethidium efflux by NorM-VC. a Effect of the buffer pH 6.0, 7.0 and 8.0 on ethidium transport by the
D36N mutant in the absence of the Δp (no Δp) (green traces) or the presence of Δψ (blue traces), ΔpH (pink traces) or Δp (orange traces). Glucose (+G)
and ionophores were added to the cells as described in Fig. 3c. The histograms show levels of ethidium fluorescence at 900 s in repeat experiments in the
absence of Na+ (open bars) or in the presence of 1 mM Na+ (horizontally-striped bars). The data show that Δψ is not a driving force for efflux by the D36N
mutant, pointing to electroneutral ethidium+/H+ antiport. bMeasurements of ethidium efflux by the D371N mutant also indicate electroneutral ethidium+/H+
antiport. Data represent observations in three experiments (n= 3) with independently prepared batches of cells. Values indicate mean ± s.e.m. (two-way
analysis of variance; **P < 0.01; ***P < 0.001; ****P < 0.0001). Asterisks above square brackets refer to comparisons with the no-Na+ condition, whereas
asterisks directly above bars or groups of bars (indicated by horizontal line) refer to comparisons with the no-Δp control; ns indicates ‘not significant’.
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of NorM-VC and NorM-PS must be different. A previous study
on 4,6-diamidino-2-phenylindole (DAPI) transport by NorM-PS
reported electroneutral DAPI2+/2H+ antiport with a role of D38
in proton coupling23. The energetics of drug transport by NorM-
PS is, therefore, drug dependent suggesting that the contributions
of catalytic carboxylates to drug/ion antiport in MATE trans-
porters can be affected by different binding mechanisms of drugs.
Given the differences in the energetics of ethidium transport by
NorM-PS and NorM-VC, a set of chimaeric proteins was gen-
erated in which the N-lobe of NorM-PS was fused with the C-lobe
of NorM-VC, and vice versa. The active ethidium efflux by the
chimaeras with wildtype domains (nPS-cVC and nVC-cPS) is
based on Na+-independent, electroneutral H+/ethidium+ anti-
port (Fig. 8c, d). This activity is similar to that of NorM-PS and
NorM-VC-D36N, suggesting that these chimaeras lack ion-
coupling via the N-lobe and must have retained H+ translocation
in the C-lobe. This pathway (Pathway 1 in Fig. 10) contains two
acidic side chains E255 and D371 in NorM-VC. Proteins struc-
tures of NorM-VC and homologues (PDB-ID: 3MKT, 3MKU and
4HUL) suggest that the two carboxyl residues form a dyad of
ionisable side chains that mediate ion binding26–28.
In the measurements of ethidium binding to NorM proteins by
fluorescence anisotropy, high-affinity binding in wildtype NorM-
VC is Na+ dependent (Fig. 4a). The Na+ stimulation of ethidium
binding was lost for E255Q in the C-lobe and D36N in the N-lobe
(Fig. 4a), suggesting Na+ binding near these locations in the
wildtype protein. Given the essential role of D36 at the external
side of NorM-VC in Na+-coupled transport, both pockets must
be part of a single Na+ conduction pathway, designated Pathway
2 in Fig. 10, in which the Na+ ions first enter the pathway via D36
and then move across the N-lobe: C-lobe interface to E255 in the
C-lobe. The existence of Pathway 2 is supported by our MD
simulations. Whereas the MD simulations with the outward-
facing conformation of NorM-VC indicate that Na+ binds in the
D36 pocket, the simulations with the inward-facing conformation
point to the existence of a lateral Na+ permeation pathway from
D36 to E255 across the interface between the N-lobe and C-lobe
via (i) D36, Y133 and T200, (ii) A55, and (iii) T30 (Fig. S4). As
the D371N mutant retains electroneutral Na+-coupled ethidium
transport20, Na+ binding in the E255–D371N region is supported
by both a carboxyl side chain and amide side chain at position
371, although the latter does inhibit ethidium binding (Fig. 4a),
potentially due to loss in Na+ binding affinity. Changes in the
interface between the N-lobe and C-lobe in NorM-VC, through
the introduction of a Q278A or N282A mutation, result in the
loss of Na+-coupled transport (Fig. 9b). Due to this loss, elec-
trogenic ethidium/(H+, Na+) antiport for wildtype NorM-VC
shifts to electroneutral ethidium/H+ antiport for the Q278A
mutant (Fig. 9c) via Pathway 1. The N-lobe: C-lobe interface is
also altered in the chimaeric proteins, which have phenotypes
similar to the Q278A and N282A mutants with a functional
Pathway 1 only (Fig. 8).
Several conclusions can be drawn from these data (Fig. 10).
First, Pathway 2 can translocate H+, or Na+ at high Na+/H+
ratio (Fig. 3). Together with H+ translocation through Pathway 1,
this leads to electrogenic ethidium+/(1H+,1H+) antiport and
electrogenic ethidium+/(1H+,1Na+) antiport, respectively. Sec-
ond, electroneutral ethidium+/H+ antiport in NorM-VC-D36N
(Fig. 5a) is based on proton translocation via Pathway 1. Third, at
a high Na+/H+ ratio, NorM-VC-D371N mediates electroneutral
ethidium+/Na+ antiport without detectable input from H+
Fig. 6 Transport studies on NorM-PS proteins. a Effect of buffer pH 6.0,
7.0 or 8.0 on ethidium efflux by wildtype NorM-PS-expressing cells in the
absence of the Δp (no Δp) (green traces) or the presence of Δψ (blue
traces), ΔpH (pink traces), or Δp (orange traces). Glucose (+G) and
ionophores were added to the cells as described in Fig. 3c. Histograms
show levels of ethidium fluorescence at 350 s in repeat experiments. b
Ethidium efflux in glucose-metabolising cells expressing NorM-PS mutants
containing carboxyl-to-amide replacements (purple traces and bars). The
activity is compared with non-expressing control cells (grey trace and bar)
and cells expressing wildtype NorM-PS (red trace and bar). Histograms
show levels of ethidium fluorescence at 450 s in repeat experiments. Data
represent observations in three experiments (n= 3) with independently
prepared batches of cells. Values are expressed as mean ± s.e.m. (one-way
analysis of variance; ****P < 0.0001). Asterisks directly above groups of
bars (indicated by horizontal line) refer to comparisons with the no-Δp
control (a) or non-expressing control (b). The square bracket with asterisks
in b refers to the comparison with wildtype NorM-PS.
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coupling20. The mutant also mediates residual ethidium+/H+
antiport in the absence of Na+ (Fig. 5b). Hence, Na+ and H+
translocation in the D371N mutant proceed via Pathway 2 in
which H+ and Na+ compete. Pathway 1 might not be functional
in this mutant. Fourth, as E255 is essential in Pathway 1 and 2,
the E255Q mutant cannot mediate active ethidium efflux20 due to
the simultaneous inhibition of both pathways. Therefore, the
relative contributions of E255 and D371 to ion translocation are
unequal. Finally, Na+ binding to NorM-VC stimulates ethidium
binding (Fig. 4a), whereas ethidium binding is promoted at
alkaline pH (Fig. 4b) and associated with proton release20.
Therefore, Pathway 1 and 2 might facilitate different steps in the
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02081-6 ARTICLE
COMMUNICATIONS BIOLOGY |           (2021) 4:558 | https://doi.org/10.1038/s42003-021-02081-6 | www.nature.com/commsbio 11
transport cycle. In agreement with this notion, the MD simula-
tions demonstrate that protonation of D371 prevents reversed
flow of Na+ back into the Na+ translocation pathway following
the release of the sodium ion in the cytosol (Fig. S4).
In summary, using engineered chimaeric and mutant MATE
multidrug transporters, this work demonstrates in well-
established functional assays that NorM-VC contains two dis-
tinct ion translocation pathways. These pathways differ in their
+G +G
+G +G
Fig. 8 Ethidium transport by chimaeric NorM-VC/NorM-PS proteins. a Construction of chimaeric proteins nVC-cPS and nPS-cVC from NorM-VC and
NorM-PS (see also main text). b Immunoblot probed with anti-His-tag antibody shows comparable expression of NorM-VC, NorM-PS and chimaeric
proteins in plasma membrane vesicles (2 µg total membrane protein/lane). The uncropped blot is shown in Fig. S3. c Ethidium efflux by nVC-cPS (open
bars) and nPS-cVC (hatched bars) at pH 7.0 in the absence of the Δp (no Δp) (green traces) or the presence of Δψ (blue traces), ΔpH (pink traces), or Δp
(orange traces). Glucose (+G) and ionophores were added to cells as described in Fig. 3c. Activity of D36N and D38N mutants is indicated in purple. The
histograms on the right show levels of ethidium fluorescence at 500 s in repeat experiments for nVC-cPS (open bars) or nPS-cVC (hatched bars). The data
show that both chimaeric proteins mediate electroneutral H+/ethidium+ antiport. d Ethidium efflux by the chimaeric proteins is not significantly stimulated
by 1 mM Na+ in buffer pH 7.4 (black traces and horizontally-striped bars), where Na+ has 25,000-fold excess over H+. Data represent observations in
three experiments (n= 3) with independently prepared batches of cells. Bar heights indicate mean ± s.e.m. (two-way analysis of variance; **P < 0.01;
****P < 0.0001). Asterisks directly above bars or groups of bars (indicated by horizontal line) refer to comparisons with the no-Δp control. In panel d,
the square brackets refer to comparisons with the no-Na+ condition; ns indicates ‘not significant’.
Fig. 7 MD simulations of the dissociation of pre-bound Na+ from the D36/D38 pockets in outward-facing NorM-VC/NorM-PS. a Interaction energies
between bound Na+ and residues in the D36 pocket within 0.8 nm distance of the Na+ were averaged over four MD simulations from 90 to 100 ns. b
Close-up view of the D36 pocket at 100 ns for each of the four runs. The interacting residues are indicated in stick representation. c Na+ dissociation from
the D36 pocket is enhanced by protonation of D36. These simulations show that the pre-bound Na+ ion (blue sphere) was retained in all four simulations
for NorM-VC and was released from the pocket when the anionic charge in the D36 side chain was neutralised by protonation of the carboxylate. d, e MD
simulations similar to those in (a, b) for the D38 pocket in NorM-PS. In two out of four simulations with NorM-PS, Na+ was not retained but diffused away
from the D38 pocket within 100 ns. These simulations suggest that the D36 pocket binds Na+ more easily than the D38 pocket. Values are expressed as
mean ± s.e.m.
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ion selectivity and organisation in the N- and C-lobe. Our results
extend previous proposals, based on structural analyses of NorM-
VC and NorM-NG, of Na+ coupling in the C-lobe only. With
contributions of both lobes to ion coupling, NorM-VC is more
versatile than members of the DinF and eMATE subfamilies that
rely on H+ coupling in the N-lobe or C-lobe, respectively. This
conclusion is also supported by the distribution of the catalytic
carboxylates, which are present in both the N- and C-lobe in
NorM-VC but are restricted to single lobes in other MATE
subfamilies. The Na+/H+ promiscuity of NorM-VC provides
flexibility in energy coupling with fluctuations in salinity in the
natural habitats of V. cholerae. This is relevant in transitions of
the bacterium between fresh water and body fluids, and in loca-
tions where reservoirs of fresh and brackish water mix at estuaries
between river environments and maritime environments29,30.
Methods
Bacterial strains. Drug-hypersensitive Lactococcus lactis NZ9000 ΔlmrA
ΔlmrCD31, harbouring pNZ8048-derived plasmids with an inducible nisA
promoter32, was grown at 30 °C in M17 medium (Oxoid and Formedium) sup-
plemented with 25 mM glucose and 5 µg/mL chloramphenicol. For cloning in
pET19b-derived plasmids, E. coli DH5α was grown in Luria-Bertani Broth medium
supplemented with 100 µg/ml carbenicillin. L. lactis strains expressing NH2-
terminal His10-tagged wildtype NorM-VC or the D36N, E255Q and D371N
mutants were described in an earlier publication20.
Site-directed mutagenesis and DNA cloning. For the generation of mutants, the
QuickChange method was applied as per the manufacturer’s instructions (Agilent
Technologies) with primers listed in Table S1. Alternatively, the ‘Round-the-Horn’
method was used with two non-overlapping primers (Table S1), one of which
contains the desired mutation at 5’ end. The primers were phosphorylated using T4
polynucleotide kinase (Thermo Fisher Scientific) as per product manual and
directly used in the mutagenic PCR reactions. A typical 50 µl PCR reaction con-
sisted of 1× buffer provided with the Phusion DNA polymerase kit (Thermo Fisher
Scientific), 0.2 mM dNTPs, 10 µM forward and reverse primer, 10 ng plasmid DNA
template and 1 unit of Phusion DNA polymerase. The PCR cycling parameters
were 98 °C for 1 min, (98 °C for 15 s, 55 °C for 30 s, 72 °C for 30 s/kb) × 20–25
cycles, 72 °C for 5 min. The amplified product was detected using agarose gel
electrophoresis. After PCR amplification, parental DNA was digested using Fas-
tDigest DpnI (Thermo Fisher Scientific). Undigested DNA was gel purified and
ligated (optional in case of QuickChange). The DNA was finally used to transform
chemically (CaCl2) competent E. coli DH5α cells.
For cloning of norM-PS, the coding sequence (GenBank ID EHY79494.1) was
optimised for expression in L. lactis using the online codon optimisation tool from
Integrated DNA Technology (IDT). A NdeI restriction site and coding region for
an NH2-terminal His10-tag were added to the 5’-terminus, and an XhoI restriction
site was added to the 3′ terminus. The synthesised gene was digested using NdeI
and XhoI restriction enzymes. Using the same restriction sites in pET19b
harbouring the norM-VC gene7, the original insert was replaced by the norM-PS
gene. Prior to subcloning into the lactococcal pNZ8048, the insert DNA was
sequenced at Eurofins Genomics. The norM-PS gene was excised from pET19b-
NorM-PS using NcoI and BamHI restriction sites and was ligated into digested
pNZ8048 vector (derived from pNZ-NorM-VC20), after which the DNA was used
to transform electrocompetent L. lactis cells. The subcloned gene was again
sequenced to confirm the original DNA sequence.
The NorM-VC and NorM-PS chimaeras were generated using the FastCloning
method33 and the primers listed in Table S1. Chimaera nVC-cPS refers to the
protein consisting of the N-lobe of NorM-VC (amino acid residues 1–224) and the
C-lobe of NorM-PS (amino acids residues 227–464), whereas chimaera nPS-cVC
refers to the N-lobe of NorM-PS (amino acids 1–226) and the C-lobe of NorM-VC
(amino acid residues 225–461). For the generation of chimaera nVC-cPS, the
primer pair NorM-VC N-lobe (fw and rev) was used to amplify the N-lobe of
NorM-VC alongside the rest of the E. coli pET19b-NorM-VC plasmid in one PCR
reaction. The primer pair NorM-PS C-lobe (fw and rev) was used to amplify the
C-lobe of NorM-PS in a separate PCR reaction. Each 50 µl PCR reaction mixture
consisted of 1× HF buffer (provided with DNA Phusion polymerase kit), 0.2 mM
dNTPs, 5 picomoles of each primer, 10 ng plasmid DNA template (pET19b-NorM-
VC and pET19b-NorM-PS) and 1 unit of Phusion DNA polymerase. The PCR
cycling parameters were 98 °C for 1 min, (98 °C for 15 s, 55 °C for 30 s, 72 °C for
30 s/kb) × 18 cycles, 72 °C for 5 min. The product was confirmed using agarose gel
electrophoresis. After PCR amplification, 1 µl of DpnI was added to the PCR
products and the two reaction mixtures were pooled together in the ratios 1:1, 1:2,
1:4 and incubated at 37 °C for 1 h to digest the template DNA. 2 µl of the digested
product was used to transform competent E. coli DH5α cells. Cloned DNA was
sequenced to confirm the fusion was obtained as intended. The chimaera nPS-cVC
was generated in the same manner as described for nVC-cPS using the primer pair
NorM-PS N-lobe and NorM-VC C-lobe (Table S1).
NorM protein expression in cells. M17 growth medium containing 25 mM
glucose and 5 µg/ml chloramphenicol was inoculated with 2.5% overnight culture
and grown to an OD660 nm of 0.5–0.6 at 30 °C. Protein expression was induced by
addition of 0.1% (v/v) of the culture supernatant of the nisin A-producing strain L.
lactis NZ970032, which results in a final concentration of ~10 pg nisinA/ml. Further
increase in the amount of nisin does not lead to enhanced NorM protein
expression. Cells were further grown for 1 h and were collected by centrifugation at
























































































a NorM-VC-Q278A and N282A
Fig. 9 Na+ dependency of NorM-VC-mediated ethidium efflux requires a
specific domain interface. a Mutations Q278A and N282A (TM8) (in red
stick representation) are located at the interface between the N-lobe and
C-lobe, formed by TM1-TM2 (yellow) and TM7-TM8 (orange), in inward-
facing NorM-VC. b The mutations disable the stimulation by Na+ (dotted
traces) of the Δp-dependent ethidium efflux by wildtype NorM-VC in cells
in buffer pH 7.0. The histograms show levels of ethidium fluorescence at
400 s in repeat experiments in the absence of Na+ (open bars) or presence
of 1 mM Na+ (horizontally-striped bars). c Ethidium efflux in NorM-VC-
Q278A-expressing cells in the absence of the Δp (no Δp, green trace) or
the presence of Δψ (blue trace), ΔpH (pink trace), or Δp (orange trace).
Glucose (+G) and ionophores were added to the cells as described in
Fig. 3c. These data demonstrate electroneutral ethidium+/H+ antiport for
the Q278A mutant. Data represent observations in three experiments (n=
3) with independently prepared batches of cells. Values are expressed as
mean ± s.e.m. (two-way analysis of variance; ****P < 0.0001, ***P < 0.001,
**P < 0.01). Asterisks directly above bars or groups of bars (indicated by
horizontal line) refer to comparisons with the non-expressing control (b) or
no-Δp control (c). In b, the square brackets refer comparisons with the no-
Na+ condition; ns indicates ‘not significant’.
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12,300 × g for 12 min at 4 °C (Sorvall Evolution RC, SLC-6000 rotor). The pellet
was resuspended in ice-cold 100 mM potassium phosphate (KPi) buffer (pH 7.0)
and centrifuged at 4200 × g for 30 min at 4 °C. The presence of NorM proteins in
membrane vesicles was assessed on western blot probed with mouse anti-
polyhistidine tag antibody (Sigma-Aldrich, cat. no.: H1029) and goat antimouse
antibody (Sigma-Aldrich, cat. no.: A4416).
Bioenergetic considerations. The choice of lactococcal cells in these drug trans-
port studies is useful for two reasons. First, L. lactis is a simple fermentative
organism that generates ATP by substrate-level phosphorylation during (i) glucose
uptake and phosphorylation by the phosphoenolpyruvate: carbohydrate phospho-
transferase system and (ii) subsequent metabolism of the glucose-6P in the glyco-
lytic pathway34. The bacterium uses this ATP pool for a variety of processes that
include proton extrusion across the plasma membrane by the F1F0 H+-ATPase. The
outwardly-directed translocation of protons and their positive charge results in the
generation of two components: a chemical proton gradient (ΔpH, inside alkaline)
and a membrane potential (Δψ, interior negative). These components impose an
inwardly-directed force on the protons referred to as the proton motive force (Δp),
which is expressed in the equation Δp= Δψ− ZΔpH (mV). In this equation, Z=
2.3RT/F (where R is the gas constant, T the absolute temperature and F the Faraday
constant) and equals 59.1mV at 25 °C35–37. By catalysing proton/drug antiport,
MATE transporters mediate proton uptake, which consumes the Δp. Proton uptake
by secondary-active membrane transporters and proton extrusion by the primary-
active F1F0 H+-ATPase occur simultaneously and contribute to a chemiosmotic
proton circuit36 that sustains proton circulation in the cell37. Although proton
circulation plays a central role in energy transduction in L. lactis, sodium circulation
also contributes and is supported by the presence of Na+ in the M17 growth
medium. The sodium motive force (ΔpNa, interior negative and low) is defined in an
analogous way (ΔpNa= Δψ− ZΔpNa), and is generated from the Δp by electrogenic
H+/Na+ antiport activity across the lactococcal plasma membrane. In transport
assays with washed cells in KPi buffer, sodium circulation in cells is dependent on
the addition of Na+ to the buffer.
Second, L. lactis makes high demands on the nutritional composition of its
growth medium and does not generate typical bacterial intracellular energy
reserves such as polyhydroxybutyrate or polyglucan. A short incubation of the cells
with a protonophore that dissipates the Δp, therefore, causes rapid depletion of the
intracellular ATP pool due to compensatory H+ efflux by the F0F1 H+-ATPase38.
In our previous work, we established that NorM-VC mediates ethidium uptake
(via ethidium/ion antiport) in de-energised cells upon imposition of an inwardly
directed chemical ethidium gradient across the plasma membrane (exterior high).
We also observed drug uptake by multidrug transporters in the ABC and MFS
families under these conditions38–42. We frequently use this method to preload
cells with ethidium and establish an intracellular ethidium pool, prior to initiating
ethidium efflux by glucose addition. The metabolism of glucose allows the cells to
again generate ATP and Δp, as well as a substantial ΔpNa when Na+ is present in
the external buffer at a sufficient concentration38.
Ethidium transport measurements. Ethidium is a lipophilic monovalent cation
that, in contrast to many antibiotics, lacks moieties that can accept or donate
protons in the physiological pH range43. Therefore, ethidium is ideal for studying
energy coupling in secondary-active multidrug transporters that contain separate
translocation pathways for H+ and substrates. To prepare cells for ethidium
transport measurements, the cells were harvested by centrifugation and washed in
ice-cold wash buffer (50 mM KPi, 5 mM MgSO4, pH 7.0) by centrifugation at
3000 × g for 10 min. The cell pellet was resuspended in wash buffer supplemented
with 0.5 mM of the uncoupler 2,4-dinitrophenol20 and incubated at 30 °C for
40 min. To remove the uncoupler, the de-energised cells were washed thrice with
wash buffer by centrifugation at 3000 × g for 10 min, and resuspended in this buffer
to OD660 of 5.0. In the ethidium transport assay, the cells were diluted 10 times in
2 ml of wash buffer (unless stated otherwise) in a 3 ml glass cuvette at 30 °C. After
30 s, 2 µM ethidium bromide was added, and fluorescence was recorded. After
reaching saturation in fluorescence, 12.5 mM glucose was added to energise cells
and to initiate ethidium efflux. Where indicated, valinomycin and/or nigericin were
added 3 min before the glucose at a concentration of 0.1 μM and 0.5 µM, respec-
tively. For ethidium transport assays in K+-free Tris buffer, the wash buffer for
DNP-treated cells was 20 mM Tris-Cl (pH 7.0) containing 5 mM MgSO4. Fluor-
escence measurements were performed in a Perkin Elmer LS-55B Luminescence
spectrometer at λex of 500 nm and λem of 580 nm with slit widths of 5 and 10 nm,
respectively. Figures contain representative traces obtained in 3 or more inde-
pendent experiments with separate batches of cells. Histograms show mean levels
of ethidium fluorescence in the repeat experiments.
Membrane potential measurements. Cells were prepared as described under
‘Ethidium transport measurements’ and were diluted 10-fold in 50 mM KPi sup-
plemented with 5 mM MgSO4 at pH 6.0, 7.0, and 8.0 to attain an OD660= 0.5 in a
glass cuvette. The generation of metabolic energy in the cells was initiated by the
addition of 12.5 mM glucose and incubation for 3 min. DiOC2(3) probe (Thermo
Fisher Scientific) was added to a concentration of 10 µM after which fluorescence
was monitored at λex= 488 nm and λem= 620 nm with slit widths of 5 nm and
10 nm, respectively. When steady-state fluorescence was achieved, 0.5 µM nigericin
was added to allow conversion of the ΔpH into a Δψ. After the establishment of a
new steady-state, 0.5 µM valinomycin was added to dissipate the proton-motive
force completely. As NorM-VC activity might affect DiOC2(3) partitioning across
the membrane, the fluorescence measurements were performed in non-expressing
control cells.
Preparation of inside-out vesicles and protein purification. Inside-out oriented
plasma membrane vesicles were prepared from lactococcal cells as described20 with
modifications. Cell pellets collected from 1 L culture were resuspended in 20 ml KPi
(pH 7.0) containing 5 mg/mL lysozyme (from chicken egg white) and a tablet of
Complete-Protease inhibitor cocktail (Sigma-Aldrich) and incubated for 30 min at
30 °C. Cell lysis was performed by passing the cell suspension 3 times through a
Basic Z 0.75 kW Benchtop Cell Disruptor (Constant Systems, Northlands, UK) at
20,000 psi. The suspension containing the lysed cells was supplemented with 10 µg/
mL DNase (Sigma-Aldrich) and 10 mM MgSO4 and incubated for 30 min at 30 °C.
Following the addition of 15 mM K-EDTA (pH 7.0), the suspension was cen-
trifuged at 4 °C for 40 min at 14,000 × g (Sorvall Evolution RC-6 PLUS, F21S
rotor). The supernatant containing the membrane vesicles was retained and
Fig. 10 Organisation of the two ion translocation pathways in NorM-VC and the transport properties of mutants. H+ translocation in Pathway 1 involves
E255 and D371 in the C-lobe. Promiscuous Na+ and H+ translocation in Pathway 2 requires D36 in the N-lobe and E255 in the C-lobe. Black crosses and
text refer to inhibition (see ‘Discussion’).
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ultra-centrifuged at 125,000 × g for 50 min at 4 °C (Beckman Type-50.2-Ti rotor).
Cell pellets were resuspended in 50 mM KPi (pH 7.0) containing 10% glycerol, and
stored in liquid nitrogen. Protein concentration was determined by Bio-Rad DC
protein assay kit using bovine serum albumin as the standard.
NorM proteins were purified from inside-out membrane vesicles using metal
ion-affinity chromatography. Membrane vesicles (5 mg membrane protein/ml)
were solubilised for 4 h with mild shaking at 4 °C in 50 mM KPi (pH 8.0), 10%
(v/v) glycerol, 0.1 M KCl and 1% (w/v) n-dodecyl-β -D-maltopyranoside (DDM).
Non-solubilised membrane vesicles and cell debris were removed by centrifuging
the suspension at 208,000 × g (Beckman Type-70.1-Ti rotor) at 4 °C for 30 min.
Nickel-nitrilotriacetic acid resin (Ni-NTA) was equilibrated by washing thrice with
5 resin volumes of ultrapure water, and twice with 5 resin volumes of wash buffer A
(50 mM KPi (pH 8.0), 0.1 M KCl, 10% (v/v) glycerol, 0.05% (w/v) DDM and
20mM imidazole) at a ratio of 10 mg His-tagged protein/mL of resin. The
suspension was left on a rotating wheel for overnight binding at 4 °C. The resin was
transferred to a 2 mL volume Biospin disposable chromatography column (Bio-
Rad). After subsequent washing with 20 volumes of wash buffer A and 30 volumes
of wash buffer B (50 mM KPi (pH 7.0), 0.1 M KCl, 10% (v/v) glycerol, 0.05% (w/v)
DDM and 20mM imidazole), the His-tagged protein was eluted with 3–4 volumes
of elution buffer (50 mM KPi (pH 7.0), 0.1 M KCl, 5% (v/v) glycerol, 0.05% (w/v)
DDM and 150 mM imidazole). The eluted purified protein was kept on ice and
immediately used in experiments. Purified protein was quantified in the Micro
BCA protein assay (Thermo Fisher Scientific) using bovine serum albumin as the
standard. The purity of the protein was checked on 10% SDS-PAGE stained with
Coomassie Brilliant Blue.
Measurements of ethidium binding. To measure ligand binding by fluorescence
anisotropy44, increasing amounts of purified protein were added from a 0.4 mg/ml
stock solution in 2 ml of 50 mM KPi buffer (pH 7.0) containing 0.2 mM KCl, 0.05%
DDM and 2 µM ethidium bromide, to final protein concentrations ranging from
0.036 to 1 µM. To test the effect of Na+ on ethidium binding, 0.5 mM Na2SO4 was
included in the buffer. The effect of the proton concentration on ethidium binding
was tested by varying the pH of the buffer from 6.0 to 9.0 in steps of 0.2 through
the addition of concentrated KOH. The protein elution buffer (see above) was used
as a negative control to generate the baseline. The fluorescence anisotropy was
measured in a Perkin Elmer LS-55B Luminescence spectrometer at λex of 500 nm
and λem of 580 nm with slit widths of 10 nm each for samples equilibrated for about
2 min. The data in Fig. 4a, b were fitted to a two-sites specific-binding model and
biphasic dose-response model, respectively, in GraphPad Prism v8.4.3.
MD simulations. The MD simulations were performed using GROMACS
v2018.445. A summarising schematic of all MD simulations is presented in Fig. S5.
The all-atom Fuji force field46,47 was used for protein, lipids and ions, with TIP3P
water48. The constant temperature was set at 303 K using a Nosé–Hoover
thermostat49,50. Constant pressure was set at 1 bar using the semi-isotropic
Berendsen barostat51 or Parrinello–Rahman barostat52 with a coupling constant of
2.0 ps for both barostats. Detailed simulation conditions and methods were as
described in an earlier publication53 in which electrostatic interactions were cal-
culated using particle mesh Ewald (PME) method54 with a real-space cut-off of
1.0 nm. Lennard-Jones interactions were calculated using Lennard-Jones particle
mesh Ewald (LJ-PME) method55 with geometric approximations of the combi-
nation rules in reciprocal space. The Verlet cut-off scheme was used for the
neighbour list. The linear constraint solver (LINCS) algorithm with lincs-order of
6 was used to constrain all bonds.
As initial structures for MD simulations, we used the crystal structure of the
outward-facing conformation of NorM-VC (PDB-ID: 3MKT) and a homology
model of NorM-PS based on this structure22. Furthermore, the initial structures of
inward-facing NorM-VC and NorM-PS were based on homology models built
using the inward-facing structure of PfMATE (PBD-ID: 6FHZ). All homology
models were calculated by the SWISS-MODEL homology server (https://
swissmodel.expasy.org/) and were validated with MolProbity v4.4 (http://
molprobity.biochem.duke.edu/) following optimised hydrogen placement and all-
atom contact analysis complemented by updated versions of covalent-geometry
and torsion-angle criteria.
The topology files of proteins and lipids were generated by the GROMACS
pdb2gmx subprogram with the hydrogen virtual site option. Three protonation
states of D36, E255 and D371 in NorM-VC, all unprotonated (designated ‘n’),
D371 protonated (designated ‘d’), and E255 protonated (designated ‘e’) were tested
for inward-facing NorM-VC (vin, vid and vie) and outward-facing NorM-VC
(von, vod and voe). Equivalent states were studied for inward-facing NorM-PS
(pin, pid and pie) and outward-facing NorM-PS (pon, pod and poe), giving a
total of 12 systems. A lipid bilayer modelled for E. coli and consisting of 8
types of phosphatidylethanolamine and phosphatidylglycerol (173 molecules
of PMPE [1-palmitoyl-2-cis-9,10-methylene-hexadecanoic-acid-sn-glycero-3-
phosphoethanolamine]; 50 molecules of PMPG [1-palmitoyl-2-cis-9,10-methylene-
hexadecanoic-acid-sn-glycero-3-phosphoglycerol]; 70 molecules of PVPE [1-
palmitoyl-2-vacenoyl-sn-glycero-3-phosphatidylethanolamine]; 16 molecules of
PVPG [1-palmitoyl-2-vacenoyl-sn-glycero-3-phosphatidylglycerol]; 38 molecules
of QMPE [1-pentadecanoyl-2-cis-9,10- methylene-hexadecanoic-acid-sn-glycero-
3-phosphoethanolamine]; 35 molecules of PYPE [1-palmitoyl-2-palmitoleoyl-sn-
glycero-3-phosphatidylethanolamine]; 21 molecules of PYPG [1-palmitoyl-2-
palmitoleoyl-sn-glycero-3-phosphatidylglycerol]; 33 molecules of VYPE [1-
vacenoyl-2-palmitoleoyl-sn-glycero-3-phosphatidylethanolamine]) was generated
using the CHARMM-GUI56. This lipid composition was based on published
LC/ESI-MS/MS analyses of the plasma membrane of E. coli57. The lipid bilayer
was hydrated with 0.15M NaCl electrolyte. With the PME and LJ-PME
methods, the energy of the bilayer system was minimised using alternating
steepest-descent and conjugate gradient methods. After minimisation, the system
was equilibrated initially for 1 ns using semi-isotropic Berendsen barostat and later
for 1000 ns using semi-isotropic Parrinello–Rahman barostat with a time step of 5
fs (Fig. S5a).
The initial protein structures were embedded in the equilibrated lipid bilayers at
1000 ns using LAMBADA58 and overlapping lipids whose heavy atoms were within
0.12 nm of the heavy atoms of the protein were removed (Fig. S5a). The energy of
the system was minimised through the same procedure as the bilayer, followed by
isothermal-isobaric ensemble equilibration using semi-isotropic Parrinello–Rahman
barostat with position restraints only on the heavy atoms of the protein and not on
the heavy atoms of lipids, initially for 1 ns with a time step of 2 fs, later for 200 ns
with a time step of 5 fs. Using the final structures at 200 ns as initial structure, four
unconstrained simulations were carried out initially with a time step of 2 fs for 50 ns
with a different initial velocity, that satisfy a Maxwell-Boltzmann distribution at 303
K. Then the production runs were carried out for 500 ns with a time step of 5 fs, and
used for analysis. The calculated RMSD value during production runs of the protein
models in 5 independent simulations quickly moved towards the same plateau of
approx. 5 Å for outward-facing NorM-PS. A similar RMSD profile, with a stable
plateau value of close to 2.5 Å, is obtained for the second homologue model in our
study, of inward-facing NorM-VC. For the crystal structure of outward-facing
NorM-VC, an RMSD plateau value of 4 Å was reached. The RMSD values indicate
that the protein conformations are all stable in silico as would be observed for a real
membrane protein structure.
The following MD simulations were performed to study the interaction of Na+
in the D36-D38 pockets in outward-facing NorM proteins (Fig. S5b): (simulation i)
The final structures at 500 ns of equilibrated NorM-VC (von) and NorM-PS (pon)
were modified so that the water molecule closest to D36 and D38 was replaced with
a Na+ ion. To test whether the Na+ was retained in the pocket over time, four 100
ns equilibrium simulations were carried out with a time step of 2 fs with different
initial velocities for the NorM-VC and NorM-PS systems. Using GROMACS tool
gmx energy, interaction energies between the Na+ and surrounding residues within
0.8 nm distance were calculated. The interaction energies were averaged over four
MD simulations from 90 to 100 ns. (simulation ii) The simulations on Na+
retainment were performed from 0 to 100 ns for outward-facing NorM-VC (von)
containing protonated D36. (simulation iii) For MD simulations of direct binding
of Na+ in the D36-D38 pockets, four 500 ns trajectories were determined for
NorM-VC (vod), in which Na+ binding was observed, and for the equivalent
NorM-PS (pod). The minimum distances between Na+ in the external
environment and D36-D38 were calculated using the GROMACS tool gmx
mindist. MD simulations of direct binding of Na+ in the D36-D38 pockets were
also performed for all 12 systems of inward-facing and outward-facing NorM-VC
and NorM-PS using protocols analogous to simulation iii above.
To study the Na+ permeation pathway in inward-facing NorM-VC, the Na+-
bound structure of one of four simulations of NorM-VC (vin) at 500 ns served as
the initial structure for four 100 ns-simulations with a time step of 2 fs and with a
different initial velocity (Fig. S5c). Subsequently, the production runs were carried
out for 100 ns with a time step of 4 fs. For one of four obtained trajectories, the
bound Na+ to D36 was specified at 0 ns, then the minimum distance between the
Na+ and D36 was calculated using the GROMACS tool gmx mindist. The
minimum distance between Na+ and E255 was calculated for the trajectory in
inward-facing NorM-VC (vid) over 1 µs, during which trapping of Na+ near E255
was observed.
Statistics and reproducibility. The data points in whole cells studies and fluor-
escence anisotropy measurements were obtained in three or more experiments
using independent batches of cells and purified proteins. The significance of data
was tested by ANOVA. Asterisks directly above bars or groups of bars (indicated
by horizontal line) in the histograms refer to comparisons with the control (e.g. no-
Δp condition or non-expressing cells); asterisks above square brackets refer to
specific comparisons; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not
significant. Specific details are included in the figure legends.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data that support the findings of this study have been deposited in the University of
Cambridge research repository Apollo with DOI link https://doi.org/10.17863/
CAM.64600 (ref. 59) or are available from the corresponding author upon reasonable
request.
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